510(k) K261362
- Device
- Xpert Hemorrhagic Fever
- Applicant
- Cepheid
- 510(k) number
- K261362
- Product code
- QVR
- Decision
- Substantially Equivalent (SESE)
- Decision date
- 2026-08-07
- Date received
- 2026-04-27
- Regulation
- 866.4000
- Classification name
- Multiplex Nucleic Acid Detection System For Biothreat Agents
- Medical specialty
- Immunology
- Review panel
- Immunology
- Device class
- 2
- Clearance type
- Dual Track
- Statement or summary
- Summary
- Third party reviewed
- N
Applicant Contact#
- Contact
- Suzette Chance
- Address
- 904 Caribbean Dr. Sunnyvale CA US 94089 94089
FDA Registration Numbers#
- 3004530258
- 3016838963
- 3010770794
Source Documents#
Other 510(k) Records For Product Code QVR#
| 510(k) | Device | Applicant | Decision date |
|---|---|---|---|
| K262971 | Xpert® Hemorrhagic Fever Panel | Cepheid | 2026-10-30 |
| K231336 | T2 Biothreat Panel | T2biosystems, Inc. | 2023-09-15 |
| K213362 | BioFire Global Fever Special Pathogens Panel; BIOFIRE SHIELD Control Kit for the BioFire Global Fever Special Pathogens Panel | Biofire Defense, LLC | 2023-03-22 |